I-MAB BIOPHARMA

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. .

#SimilarOrganizations #People #Financial #Website #More

I-MAB BIOPHARMA

Social Links:

Linkedin

X

Industry:

Biotechnology Pharmaceutical Product Research

Founded:

2016-01-01

Address:

Shanghai, Shanghai, China

Country:

China

Website Url:

http://www.i-mabbiopharma.com

Total Employee:

51+

Status:

Active

Contact:

+862160578000

Email Addresses:

[email protected]

Total Funding:

815 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx IPv6 Microsoft Azure DNS

Similar Organizations

inventisbio-logo

InventisBio

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

salubrisbio-logo

SalubrisBio

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

visen-pharmaceuticals-logo

Visen Pharmaceuticals

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

Current Employees Featured

jingwu-zang_image

Jingwu Zang
Jingwu Zang Chairman and CEO @ I-Mab Biopharma
Chairman and CEO

taylor-guo_image

Taylor Guo
Taylor Guo Chief Scientific Officer & Co-Founder @ I-Mab Biopharma
Chief Scientific Officer & Co-Founder
2016-08-01

jielun-zhu_image

Jielun Zhu
Jielun Zhu Chief Financial Officer @ I-Mab Biopharma
Chief Financial Officer
2018-08-01

Founder

jingwu-zang_image

Jingwu Zang

taylor-guo_image

Taylor Guo

Stock Details

Company's stock symbol is NASDAQ:IMAB

Acquisitions List

Date	Company	Article	Price
2017-03-23	Tianjing Biotechnology (Shanghai) Co	Tianjing Biotechnology (Shanghai) Co acquired by I-Mab Biopharma	N/A

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - I-Mab Biopharma

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - I-Mab Biopharma

alyeska-investment-group_image

Alyeska Investment Group

Alyeska Investment Group investment in Post-IPO Equity - I-Mab Biopharma

avidity-partners_image

Avidity Partners

Avidity Partners investment in Post-IPO Equity - I-Mab Biopharma

lake-bleu-capital_image

Lake Bleu Capital

Lake Bleu Capital investment in Post-IPO Equity - I-Mab Biopharma

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - I-Mab Biopharma

gic_image

GIC

GIC investment in Post-IPO Equity - I-Mab Biopharma

octagon-capital-partners_image

Octagon Capital Partners

Octagon Capital Partners investment in Post-IPO Equity - I-Mab Biopharma

invus_image

Invus

Invus investment in Post-IPO Equity - I-Mab Biopharma

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Post-IPO Equity - I-Mab Biopharma

Official Site Inspections

http://www.i-mabbiopharma.com Semrush global rank: 3.35 M Semrush visits lastest month: 4.74 K

Host Informations
Whois Informations

Loading ...

More informations about "I-Mab Biopharma" on Search Engine